Compare NBTX & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | NRDS |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 886.9M |
| IPO Year | 2020 | 2021 |
| Metric | NBTX | NRDS |
|---|---|---|
| Price | $22.35 | $14.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $8.00 | ★ $15.40 |
| AVG Volume (30 Days) | 46.3K | ★ 846.2K |
| Earning Date | 09-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $11,930,711.00 | ★ $795,000,000.00 |
| Revenue This Year | N/A | $22.09 |
| Revenue Next Year | $136.64 | $7.18 |
| P/E Ratio | ★ N/A | $15.93 |
| Revenue Growth | N/A | ★ 24.71 |
| 52 Week Low | $2.82 | $7.55 |
| 52 Week High | $30.35 | $16.24 |
| Indicator | NBTX | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 58.37 |
| Support Level | $20.83 | $15.27 |
| Resistance Level | $22.05 | $15.87 |
| Average True Range (ATR) | 0.89 | 0.62 |
| MACD | 0.07 | -0.10 |
| Stochastic Oscillator | 88.34 | 51.23 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.